Richard Nkulikiyinka

Richard Nkulikiyinka

Company: Bayer

Job title: Vice President, Head of Therapeutic Area Cardiology & Nephrology

Seminars:

Assessing the Current & Future Landscapes for Preclinical Models 12:40 pm

Dissecting the advantages and disadvantages of current established preclinical models Ascertaining what should be done to improve translatability of animal models without extending drug development timeline Expanding our understanding of mechanisms driving safety for HFpEF targeted candidatesRead more

day: Day One

Establishing a Consistent Framework & Endpoints to Optimize Clinical Trial Design 11:20 am

Evaluate whether new therapeutics should be included or be tested side by side to approved inhibitors Improve the predictability of endpoints from Phase I to Phase II, and Phase II to Phase III clinical trials Map out the most promising surrogate endpoints and biomarkers that allow for earlier identification of drug efficacyRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.